Effectiveness and Tolerability of Second-Line Therapy with Vildagliptin Versus Other Oral Agents in Type 2 Diabetes (EDGE): Post Hoc Sub-Analysis of Bulgarian Data

OBJECTIVES: Metformin is an established first-line treatment for type 2 diabetes mellitus (T2DM) patients but intensification of oral anti-diabetic therapy is usually required over time. The effectiveness of diabetes control with vildaGliptin and vildagliptin/mEtformin (EDGE) study compared effectiv...

Descripción completa

Detalles Bibliográficos
Autor principal: Kamenov, Zdravko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269645/
https://www.ncbi.nlm.nih.gov/pubmed/25245616
http://dx.doi.org/10.1007/s13300-014-0083-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269645/
https://www.ncbi.nlm.nih.gov/pubmed/25245616
http://dx.doi.org/10.1007/s13300-014-0083-x

Ejemplares similares